Nektar Therapeutics (NKTR) Interest & Investment Income (2010 - 2026)

Nektar Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 47.6% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $11.8 million (down 10.25% YoY), while the FY2025 annual figure was $10.4 million, down 28.01% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $4.2 million, up from $2.8 million in the prior quarter.
• The five-year high for Interest & Investment Income was $5.2 million in Q3 2023, with the low at $2.0 million in Q2 2025.
• The 4-year median for Interest & Investment Income is $3.9 million (2024), against an average of $3.7 million.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income sank 49.53% in 2025, then jumped 47.6% in 2026.
• Nektar Therapeutics' Interest & Investment Income stood at $4.6 million in 2023, then sank by 36.28% to $2.9 million in 2024, then slipped by 5.64% to $2.8 million in 2025, then surged by 52.81% to $4.2 million in 2026.
• Business Quant data shows NKTR's Interest & Investment Income at $4.2 million in Q1 2026, $2.8 million in Q4 2025, and $2.8 million in Q3 2025.